News | July 17, 2013

Froedtert and The Medical College of Wisconsin Clinical Cancer Center Joins Elekta, Philips on MRI-Guided Radiation Therapy

Group to explore potential of innovation that integrates MRI technology and radiation therapy delivery

July 17, 2013 — Elekta and Royal Philips announced that the Froedtert and The Medical College of Wisconsin Clinical Cancer Center (Milwaukee, Wis.) will join a consortium that is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.

"The Froedtert and Medical College of Wisconsin Clinical Cancer Center is an exceptional addition to the consortium," says Tomas Puusepp, Elekta President and CEO. "It is a nationally renowned cancer research institute, boasts in-depth expertise in every kind of cancer, is staffed by fully coordinated specialist teams and uses the latest innovative therapies and technologies."

The Froedtert and Medical College of Wisconsin Clinical Cancer Center is the fifth member to sign the research agreement to evaluate the new technology, which unites radiation therapy and MRI in a single system. Current clinical members of the group include the University Medical Center Utrecht (Utrecht, the Netherlands), The University of Texas MD Anderson Cancer Center (Houston, Texas), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands) and Sunnybrook Health Sciences Centre (Toronto, Ontario).

Integrating an advanced 1.5 Tesla MRI machine with a sophisticated adaptive radiation therapy system will provide physicians with depictions of a patient's soft tissues and tumor and allow them to dynamically track their motion. This innovation is designed to enable clinicians to deliver radiation under real-time MR guidance.

"We are eager to join this consortium of leading institutions. The research and clinical faculty of our cancer center will bring a wealth of expertise and experience to the exploration of MR-guided radiation therapy," says J. Frank Wilson, M.D., chairman, director emeritus of the Froedtert and Medical College of Wisconsin Clinical Cancer Center. The delivery system of the future will be adaptive, enabling real-time changes to radiation treatments that respond to changing anatomy, tumor response and potentially to changes in tumor biology that occur during treatment."

"Combining adaptive radiation therapy with real-time MR imaging is a powerful new concept that has the potential to redefine the standard of care in radiation oncology," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "Partnering with clinical centers of excellence like the Froedtert and The Medical College of Wisconsin Clinical Cancer Center will enable us to explore the clinical applications of this new technology and ultimately create the future of healthcare."

The integrated MRI-guided radiation therapy system is in development and not available for sale.

Website: www.elekta.com

 

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
Technology | Magnetic Resonance Imaging (MRI) | June 27, 2018
June 27, 2018 — Zetta Medical Technologies announced the release of Zoom, its latest...
Overlay Init